USPTO serial 79352690
ICAMUN BIOTHERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 5, 2024
- Examiner
- STANWOOD, STEPHEN D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ICAMUN BIOTHERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Suzhou Aikailiyuan Biotech Ltd.
Jiangsu Free Trade Zone, CN
Suzhou Aikailiyuan Biotech Ltd.
Jiangsu Free Trade Zone, CN
Suzhou Aikailiyuan Biotech Ltd.
Jiangsu Free Trade Zone, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith Birch Stewart Kolasch & Birch LLP8110 Gatehouse Road, Suite 100EFalls Church, VA 22042UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical purposes for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, and pain; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, and pain; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, hyperlipidemia, hypertension, pulmonary hypertension, cancer, diabetes, infectious diseases, hypercholesterolemia, allergies, inflammation, and pain; human vaccine preparations; antibiotics for human use; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; dietetic preparations adapted for medical purposes; depuratives for the body; Veterinary diagnostic reagents; veterinary vaccines; anti-infective products for veterinary use; veterinary preparations, namely, pain relief medication; Enzymes for veterinary purposes; biocides; babies' diaper-pants; cotton for medical purposes; medicinal preparations to facilitate teething; diapers for pets | ACTIVE | — |
| 010 | Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; surgical apparatus and instruments for medical use; surgical apparatus and instruments for dental use; radiological apparatus for medical purposes; sanitary masks; protective masks for medical purposes; babies' bottles; Intra-uterine contraceptive devices; diaphragms for contraception; artificial heart valves; orthopedic apparatus for diagnostic and therapeutic use; suture materials | ACTIVE | — |
| 035 | Advertising services; business consulting services; marketing services; personnel management consultancy; updating and maintenance of data in computer databases; accounting services; rental of vending machines; retail drug store services; wholesale drug store services; wholesale and retail store services featuring medical supplies | ACTIVE | — |
| 042 | Scientific research and development; chemical research; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; biotechnology research; pharmaceutical drug development services; pharmaceutical drug research services; drug testing services, namely, drug screening for scientific research purposes; computer software design | ACTIVE | — |
| 044 | Medical screening; provision of medical information; health counseling; health care; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical consultations; telemedicine services; mental health therapy services; physical therapy in the nature of movement therapy; veterinary specialty services providing advanced medical, diagnostic or surgical services for animals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Suzhou Aikailiyuan Biotech Ltd.
- Other trademarks owned by Suzhou Aikailiyuan Biotech Ltd.
- Other trademarks owned by Suzhou Aikailiyuan Biotech Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ICAMUN BIOTHERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 9, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 10, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 10, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 20, 2023 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 17, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 13, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |